EC Number |
Inhibitors |
Structure |
---|
3.1.3.21 | (2S,4S,5R,6R)-5-(acetylamino)-6-[(1R,2R)-1,2-dihydroxy-4-phosphonobutyl]-2,4-dihydroxytetrahydro-2H-pyran-2-carboxylic acid |
- |
|
3.1.3.21 | (2S,4S,5R,6R)-5-(acetylamino)-6-[(1R,2R)-1,2-dihydroxy-4-phosphonobutyl]-4-hydroxy-2-methoxytetrahydro-2H-pyran-2-carboxylic acid |
- |
|
3.1.3.21 | Ba2+ |
- |
|
3.1.3.21 | Ca2+ |
- |
|
3.1.3.21 | Cd2+ |
- |
|
3.1.3.21 | Cl- |
- |
|
3.1.3.21 | Co2+ |
- |
|
3.1.3.21 | Cu2+ |
- |
|
3.1.3.21 | dimethyl (6R)-5-(acetylamino)-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-4-phosphonobutyl]-alpha-L-threo-hex-2-ulopyranosidonate |
- |
|
3.1.3.21 | disodium [(6R)-5-(acetylamino)-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-4-phosphonobutyl]-alpha-L-threo-hex-2-ulopyranosonato-kO2](dioxido)oxovanadate(2-) |
- |
|